Trials / Conditions / Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
4 registered clinical trials studyying Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Synd NCT07468916 | Jonsson Comprehensive Cancer Center | Phase 2 |
| Terminated | Luspatercept With or Without Hydroxyurea for the Treatment of Myelodysplastic/Myeloproliferative Neoplasms Wit NCT05005182 | Mayo Clinic | Phase 2 |
| Terminated | Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial NCT03878524 | OHSU Knight Cancer Institute | Phase 1 |
| Active Not Recruiting | Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT03862157 | M.D. Anderson Cancer Center | Phase 1 / Phase 2 |